Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced neutropenia Read more
Sugemalimab approval in China makes it only second drug approved globally for ENKTL: GlobalData Read more
Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData Read more
Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in CVDs: GlobalData Read more
